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322 The Journal of Thoracic and Cardbjective: We aimed to evaluate and compare the efficacy of the bicaval and the
iatrial standard techniques in orthotopic heart transplantation.
ethods: A systematic review with meta-analysis was performed. As data sources,
e used the electronic databases EMBASE and Medline (1966–August 2006), hand
earching in 4 journals, expert consultation, and reference lists of reviews. Obser-
ational and randomized and prospective and retrospective controlled trials that
eported outcomes on the 2 techniques of heart transplantation were considered.
esults: A total of 23 retrospective and 18 prospective studies were included. Meta-
nalyses of prospective trials including between 228 and 472 patients revealed signif-
cant superiority of the bicaval technique in comparison with the biatrial procedure for
arly atrial pressure (weighted mean difference,3.95; 95% confidence interval,6.50
o 1.40), perioperative mortality (odds ratio, 0.41; 95% confidence interval, 0.17 to
.98), tricuspid valve regurgitation (odds ratio, 0.23; 95% confidence interval, 0.15 to
.36), and sinus rhythm (odds ratio, 7.01; 95% confidence interval, 2.57 to 19.13). The
atter also showed a significant difference in the analysis of retrospective studies (odds
atio, 2.69; 95% confidence interval, 1.55 to 4.66).
onclusion: In summary, this systematic review and meta-analysis provides evi-
ence of clinically relevant beneficial effects of the bicaval technique in comparison
ith those of the standard technique. Nevertheless, the longer-term beneficial effects
f the bicaval technique remain to be evaluated.
ince the first reported case in 1967,1 heart transplantation has become t
treatment of choice for patients with end-stage heart failure. Today, more than
3000 heart transplantations are performed yearly worldwide.2 During several
ecades, the biatrial or standard technique for orthotopic cardiac transplantation, based
n the description of Cass and Brock3 and Lower and Shumway,4 has been used
uccessfully. This technique requires, to some extent, the excision of the posterior part
f the donor left atrium and incision of the right atrium from the inferior vena cava
oward the right atrial appendage to avoid injury of the sinus node. The atrial anasto-
oses can be performed straightforward, reducing from 8 possible single-vessel anas-
omoses for complete transplantation to 4. However, there are theoretic disadvantages
ith this standard technique, including enlarged, figure-of-eight configured right and left
tria probably interfering with their contractile and electrophysiologic, as well as
ricuspid and mitral valve, functions.5 Two alternative techniques of orthotropic he
ransplantation were developed and introduced into clinical practice around 1990 to
vercome these potential imperfections. In 1989, Banner and colleagues,6 from the
arefield Group, introduced the total transplantation technique that preserves the integ-
ity of both the donor atria by anastomosing pulmonary veins as a cuff on each side of
he heart and also the vena cava separately. Sievers and co-workers,7 in 1991, and th
ythenshawe group,8 in 1993, introduced into clinical practice the bicaval transp
ation technique, which is characterized by 2 arterial, 1 left atrial, and 2 caval anasto-
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TXoses, preserving the right atrium intact and leaving only a
mall posterior part of recipient left atrial tissue between both
ulmonary veins.
There are several studies comparing these 3 different
echniques of orthotopic heart transplantation that have also
een summarized in recent reviews.9-11 It is essential t
ummarize and appraise the available studies under the
igorous methods of evidence-based medicine to help in the
ecision making on what technique should be preferred.
his has not been done thus far.
We therefore aimed to compare the more recent bicaval
eart transplantation techniques (Figure 1),6,7 both com-
ined under the term “bicaval techniques,” with the standard
rocedure (Figure 1) for clinically relevant outcomes 
Abbreviation and Acronym
CI confidence intervalThe Journal of Thoracicy implementing the methods of a systemic review and
eta-analysis, to achieve the best available level of evi-
ence for that subject.
aterials and Methods
ata Collection
o obtain the most comprehensive evidence base, we implemented
independent literature search strategies: a search in electronic
atabases, hand searching, consultation of an experienced cardio-
ascular surgeon (HHS), and reference lists of recent reviews.
We conducted a literature search in PubMed and the database
f the German Institute of Medical Documentation and Informa-
ion, including EMBASE and Medline, from 1966 through August
006 using the following search strategy: [(“heart transplantation”)
R (“cardiac transplantation”) AND bicaval]. In addition, the
ochrane library of systematic reviews was visited.
For a hand search, the 4 journals (The Annals of Thoracic
urgery, The European Journal of Cardiothoracic Surgery, The
ournal of Heart and Lung Transplantation, and The Journal of
horacic and Cardiovascular Surgery) that provided the most
Figure 1. Schematic drawings of the
standard biatrial heart transplantation
technique (A)6 and the 2 bicaval tech-
niques (B6 and C7), both preserving the
right atrium intact.and Cardiovascular Surgery ● Volume 134, Number 5 1323
sA
t
a
F
r
p
s  lan
g
O
s
W
h
i
t
d
a
D
T
c
a
b
d
I
o
w
s
t
s
a
t
Q
r
f
a
c
O
A
g
w
a
i
n
1
a
t
n
s
d
p
p
p
r
r
i
s
l
o
S
W
r
p
r
4 as
u
m
r
a
C
s
r
p
a
b
m
p
R
L
P
9
a
w
h
t
f y, we
i
D
T
t
e Four
r
c
i
L by
S s
(
i 53
p
d
a
p
m s
Cardiothoracic Transplantation Schnoor et al
1
TXtudies on the use of the bicaval technique thus far were identified.
hand search was then performed for the period from 1999
hrough June 2005.
In addition, HHS was asked to give hints on further literature
nd research groups that were not covered by the achieved studies.
urthermore, the reference lists of recent reviews were checked for
elevant literature. Studies had to evaluate orthotopic heart trans-
lantation by using the bicaval technique to be eligible for inclu-
ion.6,7 We included only studies in the English or German-
uages. The search was not limited to randomized controlled trials.
bservational controlled and uncontrolled, prospective and retro-
pective studies were included. The search was not age restricted.
e excluded letters, comments, case reports and series, and non-
uman studies.
A 2-stage filter process applying the eligibility criteria was
mplemented by screening titles and abstracts first and then full
exts. Both stages of the filter process were performed indepen-
ently by 2 investigators (DL, TS). Results were then compared
nd showed identical results.
ata Extraction and Critical Appraisal
he data extraction and critical methodologic appraisal of the in-
luded studies was undertaken by MS. Levels of evidence were
ssigned to each study according to the Oxford Centre of Evidence-
ased Medicine. For the detailed methodologic assessment, a stan-
ardized form, which was developed on the basis of the Scottish
ntercollegiate Guideline Network checklist, and an evaluation sheet
f the German Institute for Quality and Efficiency in Health Care
ere used. Both are standardized instruments for the quality as-
essment of randomized controlled trails. The extracted informa-
ion included lead author, publication year, intervention and ob-
ervation period, study group characteristics (number, sex, and
ge), indication, criteria of inclusion and exclusion, techniques of
he operation, statistical methods, outcomes, and adverse events.
uantitative results, either as means and standard deviations or
ates, were summarized in tables.
With respect to the methodologic quality of the study, we
urther appraised the randomization process (sequence generation
nd allocation concealment), blinding, statistical methods, baseline
haracteristics of both groups, and handling of losses to follow-up.
utcome Measures
ll reported outcomes were retrieved and could be divided into 3
roups. The first group included clinically relevant outcomes,
hich were assessed in more than 2 studies in a comparable way
nd on which a meta-analysis could be performed. This group
ncluded intraoperative ischemic time of transplantation, perma-
ent pacemaker insertion, early mortality (30-day mortality),
-year survival, 3-year survival, duration of hospital stay, and
trial pressure in the early postoperative period. Furthermore,
ricuspid valve regurgitation and sinus rhythm after cardiopulmo-
ary bypass, although measured at different time points in pro-
pective studies (Table E1), were considered.
A second group included outcome parameters that were
etermined in few studies only or at different time points:
ulmonary vascular resistance, hemodynamic parameters (eg,
ulmonary artery pressure, systolic blood pressure, right atrial
ressure, cardiac index, and cardiac output), tricuspid valve i
324 The Journal of Thoracic and Cardiovascular Surgery ● Novegurgitation examined in retrospective studies, mitral valve
egurgitation, need for a temporary pacemaker, and duration of
ntensive care unit stay.
The last group included outcomes that were determined only in
ingle studies, such as the hemodynamic vasomotor responses to
ower body negative pressure. These results were not considered in
ur review.
tatistical Analyses
e reported and summarized descriptive results as either means or
ates according to the original publications. Meta-analyses were
erformed for outcomes as mentioned above for prospective and
etrospective controlled trials separately. The software RevMan
.2 (Cochrane Collaboration, http://www.cc-ins.net/RevMan/) w
sed for these analyses. Odds ratios or weighted differences of the
eans and corresponding 95% confidence intervals (CIs) were
eported as measures of association and stability. Heterogeneity
mong studies for every outcome was assessed by using the
ochrane Q test. Fixed-effect models were chosen in case no
ignificant heterogeneity among studies was observed. Otherwise,
andom-effect models are presented. Sensitivity analyses were
erformed by comparing random and fixed-effect models, evalu-
ting the effect of omitting influential studies, presenting funnel
lots for parameters in which fixed-effect models were used with
ore than 3 included studies, and omitting studies with overlap-
ing patient samples.
esults
iterature Search
ubMed revealed 90 and EMBASE and Medline revealed
5 potentially relevant studies. Duplicates were excluded,
nd a total of 95 references remained. In addition, 9 studies
ere provided by HHS, and 5 studies were identified by
and searching. Overall, 109 publications were retrieved. In
he 2 screening processes 38 and 30 studies were excluded
or reasons that are given in detail in Figure 2. Finall
ncluded 41 studies in our review.E1-E41
escription of the Studies
he descriptive characteristics of the included 23 retrospec-
ive and 18 prospective studies, as well as the levels of
vidence, are given in Tables 1 and 2, respectively. 
etrospective and 2 prospective trials were studies without a
ontrol group. The transplantation techniques could be divided
nto the standard technique described by Cass and Brock3 and
ower and Shumway4 and the bicaval technique introduced 
ievers and colleagues7 (n  30) or Banner and associate6
n  9). In 2 studies the bicaval technique was not explained
n detail.E1,E2 Overall, the retrospective studies included 7
atients undergoing heart transplantation by means of the stan-
ard technique, 203 patients undergoing heart transplantation
ccording to the method of Banner and associates,6 and 517
atients undergoing heart transplantation according to the
ethod of Sievers and colleagues.7 The prospective studiencluded 318 patients with the standard technique and 305
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TXatients with the bicaval technique.7 One study included 1
atients receiving the bicaval technique but did not specify the
ransplantation technique. Several studies were carried out in
he same setting and investigated in part the same study pop-
lation but different outcomes. Five of the retrospective stud-
esE3-E7 were conducted in the Cedars-Sinai Medical Cen
os Angeles, California. One of the prospectiveE8 and one o
he retrospectiveE9 studies were conducted at the University
avia, Italy. We included 4 prospective studies of the Whythe-
shawe Hospital in Manchester, United Kingdom.E10-E13 Two
rospective studiesE14,E15 were performed at the Temple U-
ersity Hospital in Philadelphia, Pennsylvania, but at different
imes, and 3 studies were performed at the University of
iel, Germany.12,E16-E18 Because of overlapping stud
eriods, only the study with the longest study period was
onsidered.
The mean age of the population of the included studies
anged between 14.8 and 58.0 years, and the proportion
Figure 2. Flow chart of study selection.f men was about 80%. The most frequent indications for o
The Journal of Thoraciceceiving orthotopic heart transplantation were ischemic
r dilated cardiomyopathy and valvular heart diseases.
ethodologic Quality
Prospective studies. Most of the studies had potential or
bvious methodologic limitations. Two of the included 18
rospective studies were uncontrolled trails. In 9 studies the
tudy population was randomized to the operation tech-
ique, in most of them (n  8) on an alternate basis. The
atter cannot be considered as adequate because the alloca-
ion was foreseeable. One study did not describe the ran-
omization technique at all. The study population consisted
f less than 20 patients per group in 8 studies. Two studies
ailed to give information about inclusion or exclusion
riteria. The time between transplantation and observation
as shorter in the bicaval group compared with the standard
roup in 4 studies. For 2 studies the observation time point
s unknown. Another 2 studies did not give information on
he indication for transplantation. In all but 2 controlled
tudies,E14,E19 the study groups (bicaval and standard) w
omparable regarding age, sex and preoperative parameters.
ne studyE14 showed a significant age difference betwe
tudy groups, and the other studyE19 reported a significan
ifference in the preoperative right atrial pressure.
Retrospective studies. We included 23 retrospective
tudies in our review. Four of the studies were not con-
rolled by a patient group undergoing heart transplantation
y means of the standard technique. In 9 studies the allo-
ation to a study group occurred by pseudorandomization
time intervals). Some centers compared the time periods
efore and after the introduction of the bicaval technique. In
studies the observation period was shorter for the bicaval
roup than for the standard group. Four studies reported no
xact observation period. In 4 studies the sample size was
mall (20 patients per group). Inclusion and exclusion
riteria were given in 15 studies, and the indication for heart
ransplantation was given in another 15 studies.
utcomes
Meta-analyses. The results of the meta-analyses are dis-
layed in Figure 3 for prospective and Figure E1 for 
pective studies.
The intraoperative ischemic time was longer in patients
ndergoing bicaval techniques. For prospective studies, a
onsignificant weighted mean difference of 3.7 minutes was
btained (Figure 3, A). The 7 included retrospective stud
howed heterogeneity and resulted in a nonsignificant dif-
erence of 15.8 minutes (Figure E1, A).
The summary of 3 prospective studies each proved a
ignificantly reduced early atrial pressure of 4.0 mm Hg
Figure 3, B) and a significantly reduced perioperative m
ality of 59% (relative risk reduction; Figure 3, C) by mean
f the bicaval technique. The proportion of patients with
and Cardiovascular Surgery ● Volume 134, Number 5 1325
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1
TXricuspid valve regurgitation was reduced significantly by
7% in the bicaval group according to the summarized
esults of 7 prospective studies (Figure 3, D). In case th
ssessment of tricuspid valve regurgitation was graded, only
oderate and severe cases were considered, and in case
ultiple observation points were given, results of the latest
bservation were included. According to 2 prospective stud-
es, a sinus rhythm was achieved significantly more fre-
ABLE 1. Basic characteristics of included retrospective
o. Author
Publication
year Country
1 Grande and coworkersE9 2000 Italy 
2 Wang and coworkersE1 2003 Canada 
3 Solomon and coworkersE30 2004 New Zealand 
4 Milano and coworkersE24 2000 United States 
5 Meyer and coworkersE31 2005 Canada 
6 Parry and coworkersE2 1998 United Kingdom
7 Cui and coworkersE32 2001 United States 
8 Brandt and coworkersE33 1997 Germany 
9 Riberi and coworkersE27 2001 France 
10 Laske and coworkersE20 1996 Switzerland 
11 Aleksic and coworkersE3 1997 United States 
13 Freimark and coworkersE4 1995 United States 
14 Blanche and coworkersE6 1994 United States 
15 Blanche and coworkersE7 1997 United States 
16 Koch and coworkersE25 2005 Germany 
17 Bouchart and coworkersE28 1997 France 
18 Wang and coworkersE34 2000 Taiwan 
19 Park and coworkersE26 2005 South Korea 
20 Forni and coworkersE35 1995 Italy 
21 Forni and coworkersE36 1996 Italy 
22 Trento and coworkersE37 1996 United States 
23 Luciani and coworkersE38 1997 Italy 
tudy groups: Grande and Traversi; Aleksic, Blanche, Trento, and Freimar
, Banner and colleagues6; S, Sievers and associates7; NI, no informationuently with the bicaval technique (Figure 3, D). It turned n
326 The Journal of Thoracic and Cardiovascular Surgery ● Novut that the meta-analyses of prospective studies only included
hose that implemented the bicaval transplantation technique
ccording to Sievers and associates,7 with the exemption of t
tudy of Beniaminowitz and coworkers,E19 in which both b-
aval techniques were used.6,7
The summary of 4 retrospective studies showed a non-
ignificant reduction in hospital stay of 1 day in the bicaval
roup (Figure E1, B). Patients undergoing the bicaval tec
es
perative technique
No. of
cases Age
Sex
(male)
Level of
evidence
Standard 71 50.4  13.4 y 79% 2b
Bicaval (S) 46 50.9 10.8 y 80%
Standard 48 51.1 y 82% 2b
Bicaval 57 (18.51-79.56) overall
Standard 100 43  13.3 y 82% 2b
Bicaval (S) 37 (overall) overall
Standard 68 50.0  9 y 76% 2b
Bicaval (S) 75 50.0 11 y
Standard 48 55.2  12.0 y 85% 2b
Bicaval (S) 57 56.0 10.4 y 77%
Standard 17 51.6 y 83% 2b
Bicaval (S) 46 Overall overall
Standard 419 NI 72% 3b
Bicaval 415 overall
Standard 30 51.6  10.3 y 90% 2b
Bicaval (S) 30 52.8 10.9 y 87%
Standard 72 44.0 y 81% 2b
Bicaval (S) 106 48.0 y overall
Standard 20 45.0  10 y 90% 2b
Bicaval (S) 20 48.0 10 y 80%
Standard 14 54.0  10 y 73% 2b
Bicaval (B) 17 57.0 10 y 89%
Standard 15 56.4  8.2 y 67% 4
Bicaval (B) 13 53.2 8.5 y 92%
Standard 64 53.1  11.5 y 83% 2b
Bicaval (B) 40 55.8 9.7 y 92%
Standard 56 53.1  11.5 y 83% 2b
Bicaval (B) 101 57.2  11.0 y* 92%*
Standard 94 50.6  10.7 y 77% 2b
Bicaval (B) 72 49.1 14.9 y overall
Standard 65 50.0  11 y NI 2b
Bicaval (B) 30 47.0 10 y
Standard 39 49.0  12 y 75% 2b
Bicaval (S) 20 46.0 14 y 72%
Standard 15 33.1  11.8 y 77% 2b
Bicaval (S) 28 43.6 11.0 y 68%
Bicaval (S) 23 56.3  10.8 y 91% 2b
Bicaval (S) 28 52.3  10.5 y 93% 2b
Bicaval (B) 93 57.0  11.1 y 92% 2b
Bicaval (S) 69 55 y 83% 2b
ni and Luciani. See the online-only reference list for further information.
 .05.studi
O
 
k; Forique also had a nonsignificant 88% risk reduction for a
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TX
ermanent pacemaker implantation (Figure E1, C). Further-
ore, 1-year and 3-year mortality was reduced in patients
ho underwent the bicaval technique by 40% and 36%,
espectively (nonsignificant; Figure E1, D and E). The sum
ary of retrospective studies also indicated a significantly
igher proportion of patients achieving sinus rhythm with
he bicaval technique (Figure E1, F).
Outcomes not included in the meta-analyses. The
uantitative results of the outcome measurements not in-
luded in the meta-analysis are shown in Table E1
ummary, superiority of the bicaval technique introduced by
ievers and associates7 is indicated for the outcomes “ne
or temporary pacemaker,”E9-E11,E20 “right atrial pressur
2 months after transplantation,”E3,E7,E21 “pulmonary artery
ABLE 2. Basis characteristics of the included prospectiv
o. Author Publication Countr
1 Pahl and coworkersE39 2003 United Sta
2 Sievers and coworkersE16 1994 Germany 
3 Leyh and coworkersE17 1995 Germany 
4 Aziz and coworkersE21 1999 United Kin
5 Aziz and coworkersE22 1999a United Kin
6 Sarsam and coworkersE40 1993 United Kin
7 Traversi and coworkersE8 1996 Italy 
8 McDowell and coworkersE41 2000 United Kin
9 Beniaminowitz and coworkersE19 1997 United Sta
10 Grant and coworkersE10 1995 United Kin
11 El Gamel and coworkersE12 1996 United Kin
12 El Gamel and coworkersE11 1995 United Kin
13 El Gamel and coworkersE13 1997 United Kin
14 Rothman and coworkersE14 1996 United Sta
15 Weisbrod and coworkersE29 2004 Australia 
16 Deleuze and coworkersE23 1995 France 
17 Jahnke and coworkersE18 1995 Germany 
18 Jeevanandam and coworkersE15 2004 United Sta
tudy groups: Sievers, Leyh, and Jahnke; Aziz, Sarsam, Grant, and El Ga
nformation. B, Banner and colleagues6; S, Sievers and associates7; NI, nressure after 1 year,”E7,E22 “cardiac index at first postop- c
The Journal of Thoracicrative day,”E22-E24 “mitral valve regurgitation,”E7,E11 “tri-
uspid valve regurgitation,”E7,E20,E24-E26 and “left atria
hrombosis.”E27,E28 No differences were seen for “pulmo-
ary vascular resistance,”E3,E9 “systolic blood pressure,”E5,E29
cardiac output,”E7,E9,E25 and intensive care unit stay.E5,E22
Sensitivity analysis. A comparison of the results of
xed- and random-effect models is displayed in Ta
2. Overall, the effect estimates did not differ subs
ially by either model. As expected, the higher variability
nder the random-effect assumption led to loss of statis-
ical significance in some cases (perioperative mortality
n prospective studies and permanent pacemaker in ret-
ospective studies).
We excluded influential studies in some models and
dies
Operative technique
No. of
cases Age
Sex
(male)
Level of
evidence
Standard 14 14.8  3.4 y NI 4
Bicaval (S) 5 17.7 3.2 y
Standard 10 49.7  13.1 y 70% 2b
Bicaval (S) 8 56.3 9.3 y 75%
Standard 12 50.3  10.4 y 83% 2b
Bicaval (S) 15 52.2  10.3 y 93%
 Standard 161 NI NI 2b
Bicaval (S) 88
 Standard 105 49.0  9.9 y 84% 2b
Bicaval (S) 96 47.0  11.2 y 88%
 Standard 20 NI NI 2b
Bicaval (S) 20
Standard 27 45.0  10 y 93% 2b
Bicaval (S) 22 50.0  12 y 73%
 Standard 7 44.7 y 100% 2b
Bicaval (S) 10 45.0 y 100%
Standard 10 NI NI 4
Bicaval (S and B) 10
 Standard 35 49.2 y 89% 2b
Bicaval (S) 31 44.1 y 81%
 Standard 13 52.0  8.5 y 77% 2b
Bicaval (S) 24 49.0  9.0 y 71%
 Standard 35 50 y 80% 2b
Bicaval (S) 40 53 y 78%
 Standard 20 49.0  6.1 y 65% 2b
Bicaval (S) 20 52.0  4.2 y 75%
Standard 33 56.0  8.0 y 73% 2b
Bicaval (S) 37 49.0  13.0 y* 76%
Standard 6 58.0  3.0 y 67% 2b
Bicaval (S) 9 49.0 4.0 y 67%
Standard 40 49.8  8.0 y 80% 2b
Bicaval (S) 41 45.6  11.0 y 80%
Bicaval (S) 9 43.0  5.9 y NI 2b
Bicaval (S) 60 52 y 63% 2b
Rothman and Jeevandam. See the online-only reference list for further
rmation. *P  .05.e stu
y
tes 
gdom
gdom
gdom
gdom
tes 
gdom
gdom
gdom
gdom
tes 
tes 
mel;ompared the results as given in Table E3. The superi-
and Cardiovascular Surgery ● Volume 134, Number 5 1327
Cardiothoracic Transplantation Schnoor et al
TXFigure 3. Meta-analyses of prospective studies. A, Ischemic time. B, Early atrial pressure. C, Perioperative
mortality. D, Sinus rhythm. E, Tricuspid valve regurgitation. OR, Odds ratio.
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TXrity of the bicaval technique was enhanced for the
utcomes “early atrial pressure” in prospective studies
nd “1-year survival” in retrospective studies. For the
utcomes “permanent pacemaker” and “3-year survival,”
s obtained in retrospective studies, the results gained
tatistical significance. Hospital stay seems to be longer
ith the bicaval technique rather than reduced when
mitting an influential study.
The funnel blot of prospective studies on tricuspid valve
egurgitation does not indicate a substantial effect of pub-
ication bias (Figure 4).
To exclude overlapping, the analyses on “early right
trial pressure” and “tricuspid valve regurgitation” in pro-
pective studies were repeated by omitting the studies of
arsam,E40 El Gamel,E12 and Aziz,E21 respectively. The
arly right atrial pressure was still reduced by 3.32 mm Hg
n the bicaval group, but statistical significance was no
onger reached (8.80; 2.17). Tricuspid valve regurgitation
as significantly reduced to the same degree in the bicaval
roup (odds ratio, 0.20; 95% CI, 0.12–0.32). In retrospec-
ive studies the analyses on “ischemic time,” “permanent
acemaker,” and “3-year survival” were repeated by omit-
ing the studies of Freimark,E5 and Aleksic,E3 respectively.
he ischemic time was longer (13.7 minutes) and the need
or permanent pacemakers (odds ratio, 0.14; 95% CI, 0.0–
1.1) and 3-year survival were reduced (odds ratio, 0.81;
5% CI, 0.29–2.25) in the bicaval group. As before, none of
hese results reached statistical significance.
iscussion
his systematic review and meta-analysis demonstrated the
ignificant superiority of the bicaval technique of orthotopic
eart transplantation compared with the standard technique
or some clinically relevant parameters, particularly right
igure 4. Funnel blot for prospective studies on tricuspid valve
egurgitation. OR, Odds ratio.trial pressure, perioperative mortality, tricuspid regurgita- p
The Journal of Thoracicion, and sinus rhythm, according to prospective studies. For
ediatric orthotopic heart transplantation, comparably ex-
ellent results have been reported with the standard biatrial
echnique.13 In addition, the biatrial technique might 
referred in certain cases of caval size mismatches, reop-
ration, or complex anatomy.
Heart transplantation in its most anatomic form would
equire 8 circumferential anastomoses of 4 pulmonary
eins, 2 venae cavae, and 2 arteries. This technique, how-
ver, has several shortcomings, such as prolonged ischemic
ime, potentially difficult accessible suture lines in case of
leeding, anastomotic stenoses, and surgical complexity.
herefore, different transplantation techniques were devel-
ped experimentally to reduce the number of anastomoses.
erman and coworkers in 195714 sutured the donor le
trium to cuffs around the pulmonary veins of the recipient
n each side, reducing the number of anastomoses to 6.
erman and associates14 left the posterior cuff of the rec-
ent left atrium in place, reducing the number of anastomo-
es to 5. Cass and Brock,3 in 1959, and Lower and Shu-
ay,4 in 1960, introduced the concept of 2 atrial an
rterial anastomoses, reducing the number of anastomoses
o 4.
This latter technique has been the standard clinical pro-
edure since 1967, when the first human heart transplanta-
ion was performed by Barnard.1 Major parts of the reci-
ent right and left atria are left in situ, the donor left atrium
s partially excised, and the donor right atrium is incised
rom the inferior vena cava to the right atrial appendage.
ostoperatively, the atria are acutely enlarged, showing a
gure-of-eight configuration.5
Theoretically, these morphologic alterations might in-
erfere with hemodynamic, electrophysiologic, innerva-
ive, and valvular function of the donor heart. Therefore
ormer experimental alternative surgical principles were
ntroduced into clinical practice recently. In 1989, Ban-
er and associates6 first used the total transplantatio
echnique, leaving the left and right atria completely
ntact. In 1991, Sievers and colleagues7 introduced clin-
cally the bicaval technique, preserving the right atrium
ntact, only using 2 vena caval anastomoses, and leaving
small bridge of recipient left atrial tissue in place for
imple left atrial anastomosis similar to those of the
tandard technique. During the last 15 years, the bicaval
echnique has become the most commonly used proce-
ure for orthotopic heart transplantation.15 Different re-
nements of the principal technique have been used, such
s interrupted sutures for the caval anastomosis with
bsorbable or unabsorbable material, and performed dur-
ng the ischemic state or even leaving some right atrial
ridge between the superior and inferior vena cava.16,17
This meta-analysis provides evidence that the ex-
ected theoretic advantages of bicaval transplantation in
and Cardiovascular Surgery ● Volume 134, Number 5 1329
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1
TXomparison with the standard technique have come true
n clinical practice. In prospective trials, a reduction in
ight atrial pressure was found. The absolute difference in
ight atrial pressure is probably of no clinical relevance at
est. Conclusions with respect to clinical relevance under
xercise with increased tricuspid regurgitation cannot be
rawn.E17
The higher rate of sinus rhythm after transplantation,
he significant reduced rate of tricuspid valve regurgita-
ion, the prevention of contraction abnormalities by the
cute atrial enlargement with the standard technique, and
he asynchrony of recipient and donor atrial innervation
robably have contributed to the beneficial hemodynamic
ffects after bicaval transplantation.18-20 The enlarge-
ent and distension of the atria after the standard tech-
ique might not only induce impairment of electrical
mpulse initiation and conduction, as well as trigger
rrhythmias,21,22 but also promote atrial thrombus form-
ion most likely avoided by the bicaval technique.23,E27
here was a trend toward reduced permanent pacemaker
equirement for the bicaval groups.E3,E7,E10,E11,E23 How-
ver, also with the standard technique, the incidence of
ermanent pacemaker implantation can be kept compa-
ably low when sinus node area is protected.E30,E33,E34
Furthermore, Bernardi24 found that the bicaval tec-
ique leads to an increased parasympathetic reinnerva-
ion compared with the standard technique, which might
e of clinical relevance because an increase in control of
lood pressure by larger reflex changes in heart rate
ight improve adaptation to various stimuli and to phys-
cal exercise.
Potential shortcomings of the bicaval technique in-
lude the marginally prolonged ischemic transplantation
ime of some minutes, which is likely of no clinical
elevance, as well as some kind of stenosis at the level of
he venous anastomoses. Both problems, however, can be
eutralized by refined surgical techniques, such as per-
orming anastomoses with the unclamped aorta and par-
ially interrupted caval sutures. Furthermore, it can be
iscussed whether the longer hospital stay (when omit-
ing an influential study) in the bicaval group is related to
he particular surgical technique or the patient’s clinical
onditions.
This review has limitations. Although we implemented
everal strategies to obtain all relevant studies, including
earches in electronic databases, hand searching, contact
ith experts, and screening of actual reference lists, it
annot be excluded that we have missed some information.
The quality of the review is reflected by the quality of the
ncluded single studies. Well-performed single studies can
rovide valid information and bear the potential advantage
f a low variability in important parameters, such as myo-
ardial protection, reperfusion techniques, or immunosup- m
330 The Journal of Thoracic and Cardiovascular Surgery ● Novression. The majority of studies were retrospective in na-
ure. These rather observational retrospective cohort studies
ave not implemented a rigorous randomization principle,
hich makes these studies prone to several biases, including
election and information bias (Level of evidence 2b). Fur-
hermore, in 2 studies it is not always ascertained that the
utcomes were obtained in a standardized and comparable
ay, which downgraded these studies to level of evidence 4
poor-quality cohort studies). We identified 7 prospective
andomized trials. All studies did not describe the random-
zation technique in detail or the randomization was on
lternate basis, which downgraded these studies to level of
vidence 2b (low-quality randomized controlled trial).
verall, the study quality was limited mainly because of a
mall sample size, lack of randomization, and blinding.
linding should be possible for the patient, and an indepen-
ent outcome assessment should be introduced.
Some reports were based on overlapping patient samples.
e therefore performed meta-analyses with results from
ifferent centers only. The results changed only marginally.
he estimate on early right atrial pressure in prospective
tudies lost its statistical significance.
Another potential limitation of meta-analysis is that dif-
erent studies assessed outcomes in different ways and at
ifferent time points. We included in the meta-analysis
tudies assessing tricuspid valve regurgitation at different
ime points. This could bias our results and should be
onsidered in the interpretation. The different time points
ould influence the pacemaker implantation, as well as the
ricuspid valve insufficiency. Especially the latter might be
mpaired by biopsy and rejection. In addition, differences in
he protocols of the practical performances of the outcome
ssessments cannot be ruled out, which might have affected
omparability. There might also be a time trend in survival
ecause of changing conditions in heart transplantation,
hich is not related to a particular transplantation technique.
A consequence for future studies should be the use of a
inimum set of clinically relevant outcomes, which must be
easured in a standardized and comparable way.
In summary, this systematic review and meta-analysis
roves evidence of clinically relevant beneficial effects of
he bicaval technique in comparison with the standard tech-
ique of orthotopic heart transplantation, which warrants
areful consideration for further decision making. As a
esult of this analysis, the perioperative mortality seems to
e reduced significantly in subjects after bicaval transplan-
ation. Nevertheless, the longer-term beneficial effects of
he bicaval technique remain to be evaluated, especially
ith regard to exercise capacityE16 and patient-oriented
utcomes, such as health-related quality of life (Short
orm–36).
We are grateful for the excellent support in medical data
anagement and hand searching by Mrs D.S. Saravi.
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TXABLE E1. Results of the comparison of the outcomes between heart transplantation with the bicaval technique and the
tandard technique
Technique
utcome parameter Design Bicaval Standard P value
emporary pacemaker
Grande and coworkers, 2000E9 R 28% 44% NS
Laske and coworkers, 1996E20 R 30% 65% .05
Wang and coworkers, 2000E34 R 20% 15% NS
El Gamel and coworkers, 1995E11 P 26% 49% .05
Grant and coworkers, 1995E10 P 32.3% 45.7% NS
Sarsam, 1993E40 P 10% 10% NS
ulmonary vascular resistance 12 mo after
transplantation (Wood units)
Grande and coworkers, 2000E9 R 1.3  0.6 1.4  0.6 NS
Aleksic and coworkers, 1997E3 R 2.7  1.7 1.7  0.7 NS
ight atrial pressure 12 mo after transplantation
(mm Hg)
Aleksic and coworkers, 1997E3 R 5  2 7 3 .07
Blanche and coworkers, 1997E7 R 4 6 .006
Aziz and coworkers, 1999E22 P 5 11 NI
ardiac index at first day (L · min1 · m2)
Milano and coworkers, 2000E24 R 3.1  0.7 2.7  0.5 .05
Deleuze and coworkers, 1995E23 R 4.1  0.9 3.8  0.7 .04
Aziz and coworkers, 1999aE21 P
First period 3.7 1.1 2.6  0.2 .02
Second period 3.9 0.5 2.5  0.6 .03
ardiac index at least 15 mo (L · min1 · m2)
Freimark and coworkers, 1995E4 2.8  0.7 2.7  0.6 NS
Leyh and coworkers, 1995E17 3.2  0.5 2.9  0.6 NS
inus rhythm at end of cardiopulmonary bypass
Laske and coworkers, 1996E20 R 100% 65% .005
Deleuze and coworkers, 1995E23 P 88% 50% .001
inus rhythm at 1 wk
Milano and coworkers, 2000E24 R 74% 50.7% .05
Rothman and coworkers, 1996E16 P 95% 58% .05
inus rhythm at 1 mo
Grande and coworkers, 2000E9 R 85% 78% NS
ardiac output (L/min) postoperatively
Koch and coworkers, 2005E25 R 5.5 5.0 NS
ardiac output (L/min) at 12 mo after
transplantation
Grande and coworkers, 2000E9 R 4.7  1.1 5.2  1.4 NS
Blanche and coworkers, 1997E7 R 5.6 5.3 NS
Koch and coworkers, 2005E25 R 5.8 5.3 NS
ulmonary artery pressure (mm Hg) at 12 mo
after transplantation
Blanche and coworkers, 1997E7 R 18.7 (95% CI, 17.5–20.0) 21.0 (95% CI, 19.4–21.8) .03
Koch and coworkers, 2005E25 R 18.5 18.5 NS
Aziz and coworkers, 1999aE21 P
First period 17.6 4.3 22.8  5.1 .01
Second period 17.4 5.8 21.9  5.8 .008
ystolic pressure (mm Hg) at least 15 mo after
transplantation
Freimark and coworkers, 1995E5 R 133  20 125  11 NS
E29 Weisbrod and coworkers, 2004 P 138  4 122  7 NS
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TXABLE E1. Continued
Technique
utcome parameter Design Bicaval Standard P value
itral valve regurgitation
Blanche and coworkers, 1997E7; 6–19 mo after
regurgitation
R
None 72% 50% .35
Mild 17% 39%
Moderate 4% 7%
Severe 0% 4%
Koch and coworkers, 2005E25; at 5 y after
transplantation
R
None 100% 98% .05
Mild 0% 0% NS
Moderate 0% 2% NS
Severe 0% 0% NS
El Gamel and coworkers, 1995E11; 3 mo after
transplantation
P
None 85% 60% .05
Mild 15% 34%
Moderate 0% 0%
Severe 0% 6%
oderate or severe tricuspid valve regurgitation
Milano and coworkers, 2000E24 R
Month after transplantation 22% 45% .05
Laske and coworkers, 1996E20 R
1-3 mo after transplantation 0% 10% NS
Blanche and coworkers, 1997E7 R
6-19 mo after transplantation 9% 43% .001
Park and coworkers, 2005E26 R
1 y after transplantation 32% 69% .029
Koch and coworkers, 2005E25 R
5 y after transplantation 14% 43% .05
El Gamel and coworkers, 1995E11 P
3 mo after transplantation 10% 12% NS
Aziz and coworkers, 1999aE21 P
2 y after transplantation 16% 32% .031
eft atrial thrombosis at least 6 mo after
transplantation
Riberi and coworkers, 2001E27 R 0% 12.5% .04
Bouchart and coworkers, 1997E28 R 0% 26.1% .01
eripheral atrial embolism at least 6 mo after
transplantation
Bouchart and coworkers, 1997E28 R 0% 13.8% NS
ntensive care unit stay (d)
Freimark and coworkers, 1995E5 R 6.0  3.6 5.8  2.3 NS
Aziz and coworkers, 1999aE21 P
First period 5.6 2.0 3.5  2.5 .007
Second period 4.5 2.5 3.2  1.9 .02
, Retrospective; NS, nonsignificant; P, prospective; NI, no information; CI, confidence interval.The Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 5 1331.e6
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TXABLE E2. Sensitivity analysis: Comparison of random- and fixed-effect models
arameter Fixed-effect model WMD or OR (95% CI) Random-effect model WMD or OR (95% CI)
rospective studies
Ischemic time 3.66 (5.52 to 12.85) 3.56 (5.52 to 12.83)
Early atrial pressure 4.97 (5.77 to4.17) 3.95 (6.50 to1.40)
Perioperative mortality 0.41 (0.17 to 0.98) 0.46 (0.18 to 1.13)
Tricuspid valve regurgitation 0.23 (0.15 to 0.36) 0.23 (0.15 to 0.36)
Sinus rhythm 7.01 (2.57 to 19.13) 7.03 (2.59 to 19.12)
etrospective studies
Ischemic time 12.22 (3.99 to 20.46) 15.77 (1.64 to 33.18)
Hospital stay 2.14 (4.61 to 0.32) 0.99 (7.83 to 5.06)
Permanent pacemaker 0.10 (0.03 to 0.33) 0.12 (0.01 to 1.02)
1-y Survival 0.57 (0.31 to 1.04) 0.60 (0.14 to 2.53)
3-y Survival 0.78 (0.48 to 1.28) 0.64 (0.23 to 1.75)
Sinus rhythm 2.69 (1.55 to 4.66) 2.59 (1.15 to 5.84)MD, Weighted mean difference; OR, odds ratio; CI, confidence interval.ABLE E3. Sensitivity analysis: Exclusion of influential studies
arameter Original model WMD or OR (95% CI)* Exclusion of study Model after exclusion WMD or OR (95% CI)*
rospective studies
Early atrial pressure 3.95 (6.50 to 1.40) DeleuzeE23 5.42 (6.69 to 4.15)
Perioperative mortality 0.41 (0.17 to 0.98) RothmanE14 0.37 (0.15 to 0.95)
Tricuspid valve regurgitation 0.23 (0.15 to 0.36) El Gamel 2E12 0.20 (0.13 to 0.32)
etrospective studies
Hospital stay 0.99 (7.83 to 5.06) MilanoE24 2.01 (1.82 to 5.84)
Permanent pacemaker 0.12 (0.01 to 1.02) BrandtE33 0.03 (0 to 0.25)
1-y Survival 0.60 (0.14 to 2.53) MilanoE24 0.33 (0.08 to 1.43)
3-y Survival 0.64 (0.23 to 1.75) RiberiE27 0.42 (0.20 to 0.89)MD, Weighted mean difference; OR, odds ratio; CI, confidence interval. *All random effect model if not specified otherwise.
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